ABCEX
Price
$8.56
Change
+$0.03 (+0.35%)
Updated
Dec 20 closing price
RNWFX
Price
$77.72
Change
+$0.12 (+0.15%)
Updated
Dec 20 closing price
Ad is loading...

ABCEX vs RNWFX

Header iconABCEX vs RNWFX Comparison
Open Charts ABCEX vs RNWFXBanner chart's image
AB Emerging Markets Multi-Asset C
Price$8.56
Change+$0.03 (+0.35%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$77.72
Change+$0.12 (+0.15%)
VolumeN/A
CapitalizationN/A
ABCEX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ABCEX vs. RNWFX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCEX is a Hold and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 62.2B vs. ABCEX (130M). ABCEX pays higher dividends than RNWFX: ABCEX (5.04) vs RNWFX (1.51). ABCEX was incepted earlier than RNWFX: ABCEX (13 years) vs RNWFX (23 years). ABCEX is a more actively managed with annual turnover of: 89.00 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than ABCEX: RNWFX (250) vs ABCEX (2500). ABCEX annual gain was more profitable for investors over the last year : 15.55 vs. RNWFX (5.86). RNWFX return over 5 years is better than : 14.39 vs. ABCEX (10.34).
ABCEXRNWFXABCEX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years23 years-
Gain YTD13.7884.549303%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets130M62.2B0%
Annual Yield % from dividends5.041.51335%
Returns for 1 year15.555.86266%
Returns for 3 years0.80-5.10-16%
Returns for 5 years10.3414.3972%
Returns for 10 years30.2142.6771%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTRS12.520.39
+3.22%
Viatris
TEO11.890.14
+1.19%
Telecom Argentina SA
DX12.570.14
+1.13%
Dynex Capital
INTT7.680.04
+0.52%
inTEST Corp
VIRX0.21N/A
-1.87%
Viracta Therapeutics